READ THE PACKAGE LEAFLET BEFORE USE
Indications:
Primary and secondary L-carnitine deficiency.
Contra-Indications:
Hypersensitivity to L-carnitine or to any of the other constituents of the product.
Special warnings and precautions during administration:
Caution should be paid when it is administered in diabetic patients and in patients with end-stage renal failure or severe suppression of renal function.
Adverse Reactions:
Various mild gastro-intestinal complaints have been reported during administration of oral levocarnitine.
Marketing Authorisation number:
Oral solution (in single dose) 1g/10 ml Vial: 022041
Oral solution (in single dose) 2g/10 ml Vial: 022042
